Skip to content

Taxes Paid at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.63B-2.6%
TG Therapeutics logo
TG TherapeuticsTGTX
$3.44M
Moderna logo
ModernaMRNA
$6.5M-86.8%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
Incyte logo
IncyteINCY
ALN
Alnylam PharmaceuticalsALNY

Other financials

Income statement

See full
Net income-$147.9M-38.9%
EPS (diluted)-$0.73-15.9%

Balance sheet

See full
Cash & equivalents$902.1M+26.4%
Total debt$72.0K-26.5%
Total equity$852.6M+20.5%
Total assets$957.0M+23.3%

Cash flow

See full
Operating cash flow-$95.1M+14.1%
CapEx$8.0K-96.0%
Free cash flow-$95.1M+14.2%

Valuation

See full
Market cap$7.26B+74.2%
Enterprise value$6.35B+89.7%

Returns & leverage

See full
Return on equity-64.8%+2.5pp
Debt / equity0.0×
Current ratio9.1×-2.1×

Where this comes from

Reported directly by Immunovant, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxesPaid.

The official record: Immunovant, Inc.’s 10-Q, filed February 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Immunovant, Inc.'s taxes paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Immunovant, Inc.'s taxes paid?
Immunovant, Inc. (IMVT) reported taxes paid of $1.64M in Q4 2025.
What does taxes paid mean?
Actual cash paid to tax authorities for income taxes during the period — may differ from income tax expense due to timing.